FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to organic chemistry and medicine and concerns new compounds of formula , a based pharmaceutical composition containing the above compounds, and a method of treating a condition or a disorder mediated by the kinurenine-3-monooxygenase activity.
EFFECT: invention extends the range of agents active in relation to kinurenine-3-monooxygenase.
17 cl, 2 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOQUINAZOLINE DERIVATIVES AND USE THEREOF IN TREATING BONE DISORDERS | 2006 |
|
RU2416602C2 |
ERK2 HETEROCYCLIC INHIBITORS AND THEIR USING | 2002 |
|
RU2300377C2 |
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | 2008 |
|
RU2464262C2 |
HETEROCYCLIC DIHYDROPYRIMIDINE COMPOUNDS | 2000 |
|
RU2296766C2 |
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
PYRAZOLES | 2006 |
|
RU2381217C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
PYRROLIDINE DERIVATIVES | 2010 |
|
RU2562605C2 |
Authors
Dates
2014-07-20—Published
2009-08-04—Filed